Premium Essay

Anti-Cancer Drug Cost Regulations- Cocontainment for the Pharmaceutical Companies

In: Science

Submitted By bbroberson
Words 2794
Pages 12
Anti-Cancer Drug Cost
Regulations- Cost-Containment for the Pharmaceutical Companies
Brenda Roberson
University of Maryland University College
Abstract
Drug development is a long, inefficient, and expensive process and takes 10 to 15 years for development at a cost of about $1.3 billion (Nelson, 2014). When speaking of research and development (R&D) for new drugs; a large number of drugs that go through research do not make it to the FDA or the marketplace. Critics of pharmaceutical companies point out that only a small portion of the pharmaceutical companies’ expenditures account for research and development (R&D). The majority of the money’s spent in marketing and administration. There is also controversy over the $1.3 billion figure as an actual cost. Reported by Nelson (2014) Dr. Kantarjian of M.D. Anderson disputes the $1.3 billion figure for development; he believes this figure to be inflated to cover ancillary expenses, salaries, bonuses, stock market returns, and other indirect costs not related to R&D.
The cost of cancer drug therapy is becoming impossible to justify or rationalize for both patient and society. New cancer drugs being approved by the Food and Drug Administration (FDA) are typically costing upwards of $100,000 per year and many times used in combination with other agents (Bunnell, 2012, p. 932) increasing the cost even more. These high priced anti-cancer drugs achieve only marginal benefit for the patient. Benefits achievements of 1.2-month prolongation of survival or progression-free survival (PFS) of 0.9-months. In addition, this prolongation of survival may include grade 3 and/or grade 4 side effect toxicities that severely decrease the quality of life (Fojo & Grady, 2009, p. 104). U.S. is a free market economy industry. And as such the pharmaceutical companies price products according to what they think their…...

Similar Documents

Premium Essay

Drug Companies

...WESTERN DRUG COMPANIES AND THE AIDS EPIDEMIC IN SOUTH AFRICA | | | | | | | | INTRODUCTION The AIDS epidemic in South Africa is at an extreme where 4.2 million of the country’s 43 million citizens are afflicted. This translates into one in every ten citizens being infected with the virus. Additionally 34 million Sub Saharan African citizens have been afflicted and 11.5 million have died and that total accounts for 83% of the world’s AIDS related deaths. Treatment is available in the form of an anti-retroviral, but it is very costly and as such unaffordable for the already impoverished nations in Africa. The AIDS crisis and the expensive treatment have caused the government of South Africa to pass laws authorising the practice of parallel importing and compulsory licensing. Parallel importing allows importers to purchase the medication from the cheapest source whether or not the patent holders gave approval and compulsory licensing allows the government to license local companies to produce cheaper versions of the drug patented by foreign companies with or without their consent. The passing of the law by the South African government caused a legal dispute with the US drug companies regarding intellectual property rights, compulsory licensing and parallel importing. The dispute caused a debate among public health officials, activists, law makers and the drug companies over the importance of public health versus corporate profits and the bad public......

Words: 1750 - Pages: 7

Premium Essay

Top Ten Global Pharmaceutical Companies

...GlobalData, highlight the top ten pharmaceutical companies by 2011 revenue. Pfizer 1 Johnson & Johnson 2 US pharmaceutical giant Pfizer maintained its top position in 2011 with stipulated revenue of $67.4 billion, up by 1% compared with $67.1 billion in 2010. The company’s new marketing strategy, coupled with focused organisational, financial and R&D restructuring efforts, compensated for the losses caused by Lipitor’s patent expiry. The approval of Xalkori for lung cancer, Inlyta and pneumococcal vaccine Prevnar 13 have proved to be a real lifeline for Pfizer. Moving ahead, the steady progress of the late-stage pipeline (with 22 projects in phase III and 11 under registration) will be a primary source of confidence for the company. The key strategy of the group is now to advance experimental drugs towards approval: these include Bosutinib, Tofacitinib, experimental clot-preventing drug Eliquis and its many pipeline drugs to make up for the inevitable decline in Lipitor revenue. With a view to reducing costs, Pfizer’s huge research budget has been cut by 12%. In 2012, Pfizer will focus on small to mid-sized deals and effective research partnerships to strengthen its portfolio in all therapeutic segments. Johnson & Johnson (J&J) reported 2011 revenues of $65 billion, a 5.6% increase over 2010. In 2011, the company generated 40% of its revenue from its medical devices and diagnostics businesses, followed by 37% from pharmaceuticals and 23% from consumer......

Words: 1560 - Pages: 7

Free Essay

Pharmaceutical Drugs and Drug Companies

...depends on how you look at it, some people conceder drug companies to be monopolistically competitive but I think it is an oligopoly. Oligopoly is a market structure with significant barriers of entry and exit, many consumers and few firms. With a close look of the drug business you will realize that is it has all the characteristics of an oligopoly started above. Because of the fewer number of firms there is always the tendency of collision, secondly in a relatively un-concentrated market barriers to entry and may simply reflect high operating cost. The high cost of getting this product to the market include clinical trials, patent approval and FDA approval; industry-financed studies claimed $114 million 1987, later went up to $231 million, $403 million, and then $2.1 billion in 2006 for FDA approval, patent approval and clinical trials. Oligopolies in most cases tend to go multinational which is largely associated with todays’ drug companies. In terms of research and development, I will say it is the backbone of the pharmaceutical industry which makes it very important. I will want to focus on Pfizer one of the big names in this industry. Pfizer’s Global Research and Development is probably the group that the company takes the most pride in for obvious reasons. If ......

Words: 536 - Pages: 3

Premium Essay

Cancer Drugs

... The Costs and challenges of the Production of Cancer Drugs Hearing the words “you have cancer,” are only the beginning of a long and horrible experience made only more difficult for the afflicted by the complexity of getting a successful treatment to those that need it. The processes of getting effective treatments to patients are influenced by economic issues, the special medical needs of those served, and by the Federal Drug Administration making sure that the risks and costs of the treatment don’t outweigh the benefits. The cost of cancer involves the cost of treatment, the cost of research, and the cost of FDA processes to get the treatments and drugs to the market. Even when the economy is good these are difficult things to meet. The costs of cancer treatment can be so devastating to both insured, and uninsured that cancer stricken patients sometimes decide not to take the treatments. Decisions must be made whether to pay the mortgage, or pay for treatments that may or may not cure the cancer. A cure for cancer has not yet been found .This year, about 580,350 US residents are expected to die of cancer, that’s nearly 1,600 people a day. Cancer is the second most common cause of death in the United States, exceeded only by heart disease. Cancer accounts for nearly one out of every four deaths in the United States (American Cancer Society, Last Revised: 02/01/2013,http://www.cancer.org/cancer/cancerbasics/economic-impact-of-cancer) According to the American Cancer......

Words: 1942 - Pages: 8

Premium Essay

Pharmaceutical Companies, Intellectual Property

...Case Study #1 “Pharmaceutical Companies, Intellectual Property, and the Global AIDS Epidemic” Questions for Review: 1. Do pharmaceutical companies have a responsibility to distribute drugs for free or at low cost in developing countries? What are the main arguments for and against such an approach? What are the advantages and disadvantages of giving drugs for free versus offering them at low no-profit prices? -I don’t necessarily think that they have the “responsibility” to do so but I think that they should want to as there are millions dying and suffering tremendously from this epidemic. Pharmaceutical companies make billions and billions of dollars a year, I feel that they should want to help people who can’t help themselves. It is not fair for them to suffer and die because they don’t have the money to treat themselves. -Arguments for: Devastating amounts of people are dying and suffering from this disease and are not able to afford proper treatments. Activists and organization believe that there shouldn’t be a price on life and that treatment should be available to these less fortunate people. -Arguments Against: It argues that they will not make enough profit. The price of research and development is outrageous and they worry that the decrease of profits will not be able to recover from the other expenses. -Giving the drug away for free could potentially hurt the supplier and it could also start corruption. If it is given for free there is no telling......

Words: 935 - Pages: 4

Free Essay

Government Regulations for New Drugs

...Government Regulations Laws in the United States for mass production and commercial use of a drug are amongst the strictest and most costly to develop in the world. US demands for prescription drugs in 2009 was $300 billion, which was a massive 40% of the world population. In terms of strictness, drugs have to go through many tests by numerous regulatory agencies before getting approved for mass production. The self-diagnostic kit that tests for Influenza, Pink eye and Respiratory Syncytial Virus (RSV) has to be approved by the Food and Drug Administration (FDA), the Consumer Product Safety Commission (CPSC) and the Environmental Protection Agency (EPA). FDA; The obvious government regulation needed is the one from the Food and Drug Administration (FDA). Before any drug, or in our case a drug diagnostic kit, hits the market, it has to go through many trials and tests before it is approved. “As with all products regulated by FDA, rigorous reviews of laboratory and clinical data are needed to ensure the safety, efficacy, purity and potency of these products.” CLIA; Due to the fact that the self-diagnostic test is going to be a commercially used product for humans, it has to be approved by the Clinical Laboratory Improvement Amendments (CLIA), which are a part of the FDA. CLIA are federal regulatory standards in the United States created in 1988 for any laboratory tests that are performed on humans. One major competitor, QuickVue, which is a diagnostic for influenza A......

Words: 865 - Pages: 4

Premium Essay

Finding Different Drugs to Cure Cancer

...ASSIGNMENT 3.1: FINDING DIFFERENT DRUGS TO CURE CANCER by Wanda G. Sellers August 21, 2013 English 115 Instructor: Professor Audrey L. Vaughan Cancer is a very devastating disease. It attacks every organ in the human body. Many people in the United States and in foreign countries have cancer. Cancer affects many people’s lives and many more people are being diagnosed with cancer each day. Everyday scientists and researchers are trying to come up with new medicines to cure cancer. In this paper, I will discuss the process of developing new drugs to treat cancer, and the costs of developing these drugs. According to the oncologists at the website Cancer.net, more doctors and scientists are always looking for better ways to treat people with cancer. To do this, they are constantly developing and studying new drugs as well as looking for new ways to use the existing drugs. When scientists are developing new drugs for cancer patients, there are many researchers involved. They must find the right chemicals before testing them to see how effective they are in helping people. Sometimes this process takes from 5 to 12 years. Sometimes it takes longer than that. After the new drugs are developed, more time has to be allowed for the Food and Drug Administration (FDA) to approve the drugs before cancer patients can take them according to Cancer.net. They do this by......

Words: 718 - Pages: 3

Free Essay

Drug Companies

...Answer: Pharmaceutical companies have ethical responsibilities that are to improve the human health and prolonged life that other corporations don’t have. In drug companies ethical values should take priority over economic efficiency. Yes, large US drug companies are good corporate citizens. Some big companies makes drug available at low cost or no cost at all to people with HIV/AIDS in poorer countries. They also donate millions of dollars to nonprofit organization that support patients with life threatening illnesses. Answer: Drug companies don’t have any obligation to make new drug available to patients, who were involved in the development. Yes size of the company does make difference. Big companies can afford to setup their office and absorb the cost of marketing strategy to make the drug available in other developing countries but smaller companies can’t do it. If I were Dr. Lange, I would at least make the drug available to those who were involved in the study. Because it would be violation of ethical obligation and exploitation of human being if they don’t provide the drugs to those patients. The consequences of that the company will be criticized and held morally irresponsible by other patients who won’t be able to get the drug. Answer: Pharmaceutical companies have moral obligation and social responsibility to make the life saving drugs available in poor countries at little or no cost. Disease and illness affect poorest the most and they die of......

Words: 327 - Pages: 2

Premium Essay

Cannabis Verses Pharmaceutical Drugs to Treat Seizure Disorders

...Cannabis verses pharmaceutical drugs to treat seizure disorders Melissa M. Phillips COM/172 April 21, 2014 Scott Tobias Cannabis verses pharmaceutical drugs to treat seizure disorders. Chronic illnesses are prevalent this day and age due to various environmental factors, lifestyle choices, and the use of pharmaceutical drugs. There are various pharmaceutical drugs to treat patients who have chronic pain, depression, anxiety, Alzheimer's, cancer, and various seizure disorders. However, the effects of pharmaceutical drugs on people’s major organs are devastating. Cannabis is a much safer, 100% natural approach to treating chronic illnesses and it is not damaging to peoples organs. In fact, the human body has built in cannabinoid receptors in the brain and the spleen, and our bodies actually create our own cannabinoid proteins, which contains no psychoactive component. Therefore, the human body creates its own cannabis. Personally, being through what I have been through with my chronic illness; Idiopathic Intracranial Hypertension (IIH), and the numerous amounts of pharmaceutical drugs I have been prescribed. I have had severe allergic reactions to various pharmaceutical drugs, a medication induced seizure, and could have possibly overdosed due to the wrong amount of medication being prescribed. Given my current situation and my new perspective on consuming something that has been on this planet for millions of years (holistic ancient medicine), or consuming something...

Words: 1670 - Pages: 7

Free Essay

Western Drug Companies

...Question One: Why is it so important for the drug companies to protect their patents? Answer: In the field of medicine, people begin to focus on intellectual property. Health care related Intellectual Property Right (IPR) is deemed as a special and complex issue, which distinguishes itself from other kinds of IPR with its particular nature and different legal provisions and covers a wide range of subjects. Firstly, medicine is a special and important field of technology. The feature of drug development is large investment, high rise and long cycle. Currently, developing a new chemical drug takes 8 to 10 billion. Moreover, it takes more than ten years to screen a drug and bring it to market. If they don’t protect their patents, new drugs that consumed significant cost will be imitation. Therefore, drug development needs more dependent on protecting patents than other sectors. Secondly, the sustainable development of pharmaceutical industry relies on strong support of new technologies and new products. The return of new drugs is huge and it is over 30 percent of sales. So the huge return needs to be protected. Otherwise it will create duplication of research and development and waste of resources. It is easy to form a vicious marketing competition and goes against technological advances in pharmaceutical industry. For example, an anti-HIV drug successes to be researched and developed in Taiwan. It is said that the effect of prevention of AIDS is 90 percent and an......

Words: 271 - Pages: 2

Free Essay

Generic Prescription Drug Cost

...Prescription Drug Costs Prescription drugs have been causing problems in the United States for a very long time. Pharmaceutical companies are one of the largest profiting global industries. It was in 2009 when drug shortages increased with numbers reaching what many have termed crisis level which raised all prices of generic prescription drugs significantly (Fox, Sweet, & Jensen, 2014). This increase was and still is leaving patients with a life threatening decision; either go on paying for their prescriptions which they cannot afford or stop their treatment all together and risk their illness progressing and leading to possible death. Some have chosen to end their treatment altogether, while other patients have confessed to taking dangerous measures to ensure their refills last longer like cutting their pills in half or skipping doses. The United States drug manufacturers are raising prices endlessly without regulation. Instead of generic brand medication being affordable, they are creating their own monopolies and setting their prices just as competitively as name brands. Instead of buying and stocking manufacturers with raw materials from within the United States, they source raw materials from overseas creating delays and a huge shortage in raw materials has surfaced. Instead of keeping the FDA in the loop as to what is going on in the production process, manufacturers wait until the very last minute to report a problem which goes against all rules, regulations,......

Words: 3188 - Pages: 13

Premium Essay

Pharmaceutical Companies and the Availability of Hiv Drugs to African Countries

...1) Is the monopoly on patented pharmaceuticals warranted? What barrier to entry prevents the re-importation into the United States of pharmaceuticals sold at lower prices abroad (say, in Canada)? Pharmaceutical companies try to maintain a monopoly in the early stages of a drug in order to recover R&D investment. During this period of exclusivity they will try to make a fair profit. This is not a monopoly in the true sense of the word because this period is limited in time. It is perhaps better to describe it as a limited warranty. There are also other limitations. Pharmaceutical companies in some countries may not respect intellectual property and may copy or produce generic drugs even before the patent expires. An important criterion of a monopoly is price control. However, in many countries, a governmental agency is responsible for setting the prices of drugs, making the influence of the manufacturers somewhat limited. This puts pressure on the manufacturers to seek overseas markets in order to maximize their chances of recovering R&D costs and to earn a profit within the period covered by the patent. By so doing the market for re-importation and parallel imports is opened. Some of the prices that the pharmaceutical manufacturers end up accepting under these circumstances do not define a true monopoly. There are several barriers to entry that prevents re-importation into the US of drugs sold at lower prices. These include the following: Price difference ...

Words: 858 - Pages: 4

Free Essay

Anti-Drug Legislation Analysis

...Anti-drug Legislation Analysis Criminal Law CJA/354 Anti-drug Legislation Analysis Prohibiting and reducing illegal drug trade is a policy of the anti-drug legislation of laws and polices discouraging any distributing, producing, and the consumption of substances. The students’ paper will focus on the federal and state legislation of marijuana. The student will compare and contrast similarities, and differences among the states of Arizona and California. The student will discuss current laws of each state and examine the proposition of legalization of marijuana. In addition the student will review the impact of legislation change at different levels of the current war on drugs in both the federal and state. The student will assess how legalization will affect asset forfeiture and if would be worthwhile. Starting in the United States of America in 1875 the city of San Francisco enacted a statute that prevented smoking opium (Schmalleger, 2010, p. 384). States quick to follow, the enactment of the Harrison Act in 1914 through medical professional was a requirement of the federal government to register and pay one dollar per year on the tax (Schmalleger, 2010 p. 384). Drug trafficking dealers not registered faced the penalty of prison time of five years and up to a fine of two thousand dollars (Schmalleger, 2010, p. 384). In 1920 the legal availability of heroin came to a halt as the courts considered heroin a prolonged addiction therefore as medical treatment was not......

Words: 1086 - Pages: 5

Free Essay

Cancer Drug Shortage

...injected drugs, which are the workhorses of hospitals but are difficult to make and produce little profit for drugmakers. The shortages are caused primarily by problems with sterility and other serious issues that have led to shutdowns of production lines and occasionally entire factories. In addition, consolidation among generic drug manufacturers, as well as manufacturers deciding to end production of marginally profitable drugs, has led to decreased capacity. That means when one manufacturer suddenly stops production, the small number of others making a drug can't quickly pick up slack. A MAJOR PRODUCTION FACILITY OF THE DRUG WAS SHUT DOWN IN NOVEMBER  there are no routine mechanisms in place requiring manufacturers to notify anyone formally that a drug may be entering into a shortage phase, why the drug is entering the shortage phase, and how long it will be in short supply. 2. The FDA said it will temporarily allow importation of a replacement drug for Doxil, a drug for ovarian and other cancers that hasn't been available for new patients for months.  The agency also approved another supplier for a preservative-free version of methotrexate, a crucial drug for children with a type of leukemia calledacute lymphoblastic leukemia and for high-dose treatment of bone cancer. The version with preservatives can be toxic or cause paralysis in children and other patients getting the drug high doses. THE DRUG SHORTAGE PREVENTION ACT Now the FDA is importing the drugs......

Words: 375 - Pages: 2

Premium Essay

Anti-Drug Analysis

...Anti-Drug legislation Analysis Joe Lamb CJA/354 May 21, 2012 Lora Terrill Anti-Drug legislation Analysis The topic of paper will focus on the numerous anti-drug policies created by federal and state legislation. Furthermore, the similarities and differences between the various states will be compared with federal policy. An analysis will further be provided regarding the legalization or decriminalization of the drug marijuana and the possible impact legalizing drugs like marijuana could have on the federal, state, and local law enforcement, corrections, and society. In 1875, San Francisco was the first state to enact a ban that prohibited individuals from smoking opium. Unfortunately, the Act targeted mainly Chinese immigrants but was a leading factor to the creation of future antidrug laws. In 1914 the Harrison Act came into effect which required all medical professionals dealing in morphine, opium, and other substances to register with the federal government and pay an annual tax of one dollar. Any individual not registered and who were caught trafficking drugs could be punished with a fine of not more than two thousand dollars and serve up to five years in prison. Before the Heroin Maintenance Act was put into effect in 1920, individuals addicted to drugs could be treated at a clinic with medially prescribed Heroin. Studies conducted over time proved that the use of heroin to treat substance abuse was only causing further damage by prolonging one's addiction and......

Words: 1639 - Pages: 7